We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
40 hedge funds and large institutions have $38.4M invested in Zevra Therapeutics in 2018 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
75% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 8
18% more funds holding
Funds holding: 34 → 40 (+6)
12% less capital invested
Capital invested by funds: $43.5M → $38.4M (-$5.09M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
40
Holders Change
+6
Holders Change %
+17.65%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
10
Increased
14
Reduced
8
Closed
4
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
-$20K
Top Buyers
| 1 |
CI
Cowen Inc
New York
|
+$2.24M |
| 2 |
Millennium Management
New York
|
+$828K |
| 3 |
Morgan Stanley
New York
|
+$699K |
| 4 |
Renaissance Technologies
New York
|
+$558K |
| 5 |
PVI
Pura Vida Investments
New York
|
+$366K |
